Enhanced SARS-CoV-2 Antibody Response After a Third Heterologous Vector Vaccine Ad26COVS1 Dose in mRNA Vaccine-Primed Kidney Transplant Recipients

Detalles Bibliográficos
Autores principales: Schimpf, Judith, Davidovic, Tamara, Abbassi-Nik, Armin, Sprenger-Mähr, Hannelore, Lhotta, Karl, Zitt, Emanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Health Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980220/
https://www.ncbi.nlm.nih.gov/pubmed/35391899
http://dx.doi.org/10.3389/ti.2022.10357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980220/
https://www.ncbi.nlm.nih.gov/pubmed/35391899
http://dx.doi.org/10.3389/ti.2022.10357

Ejemplares similares